1Kambharn N, Markowitz GS, Valeri AM, et al. Obesity - related glomerulopathy:an emerging epidemic. Kidney Int 2001 ; 59 : 1498 - 509.
2Chagnac A, Weinstein T, Herman M, et al. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003; 14:1480 - 1486.
3Engeli S, Bohnke J, Gorzelniak K, et al. Weight loss and the renin - angiotensin - aldosterone system. Hypertension 2005 ; 45 : 356 - 362.
4Wu Y, Liu Z, Xiang Z, et al. Obesity - related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples, Endocrinology 2006 ; 147 : 44 - 50.
5Gonza' lez E, Gutie' rrez E, Morales E, et al. Factors influencing the progression of renal damage in patients with unilateral renal agenesis and remnant kidney, Kidney Int 2005 ;68:263 - 270,
6Srivastava T. Nondiabetic consequences of obesity on kidney. Pediatr Nephrol 2006;21:463 - 70.
7Tran HA. Reversible obesity - related glomerulopathy following weight reduction, Med J Aust 2006; 184(7) : 367,
8Morales E, Valero MA, Leon M, et al, Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies, Am J Kidney Dis 2003;41:319 - 327.
9Chagnac A, Weinstein T, Herman M, et al. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003;14:1480-1486.
10Osman MM, Khalll A, Ahmed MH. Chloroquine - induced nitric oxide: new treatment for an emerging epidemic of obesity-related glomerulopathy. Diabetes Technol Tber 2006 ;8 : 691 - 692.